Sunshine Biopharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-573.4K | $107.5K |
| FY2018 | — | $-55.8K | $110.5K |
| FY2019 | — | $-735.4K | $40.5K |
| FY2020 | — | $-954.8K | $989.9K |
| FY2021 | — | $211.7K | $2.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-573.4K | $107.5K |
| FY2018 | — | $-55.8K | $110.5K |
| FY2019 | — | $-735.4K | $40.5K |
| FY2020 | — | $-954.8K | $989.9K |
| FY2021 | — | $211.7K | $2.0M |